BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 16, 2026
Home » Blogs » BioWorld Perspectives » A shot in the dark? ‘Flu’ Manchu-type fears of evil pharma, plus frets over strains and safety, keep too many away from vaccine

BioWorld Perspectives
BioWorld Perspectives RSS FeedRSS

BioWorld / Vaccines

A shot in the dark? ‘Flu’ Manchu-type fears of evil pharma, plus frets over strains and safety, keep too many away from vaccine

Oct. 7, 2014
By Randy Osborne

blog flu pixBy now I’ve learned to keep my flu shot habit a secret.

Every year about this time, since I was 18 years old, I get vaccinated. But long ago I stopped telling people about it, so I don’t have to hear: “Oh, you know the flu vaccines are made of antifreeze [mercury, aluminum, formaldehyde], right?” or “That’s a crazy thing to do, because the shot itself can make you sick!” or – this one’s fairly new – “You don’t really need it if you’ve got a healthy immune system. Anyway flu shots cause Alzheimer’s [in the old] and autism [in the young].”

I avoid talking about flu shots as carefully as I avoid letting strangers know that my job has anything to do with the pharmaceutical industry. As soon as they find out, they want to argue with me about drug pricing. They make tedious jokes about Viagra, medical pot and these days, nervously, Ebola. They demand to know why “the industry” (it’s a single, uniform entity) is keeping “the cure” for cancer (they think there’s just one cure) a secret. Oh wait! They already know why!

So I’ve been getting the flu shot every year since the afternoon in 1973 when I came home after seeing “The Exorcist,” and collapsed on the floor in the fetal position.  Every muscle in my body ached, as if I had been beaten with telephone books. My skin was hot. I shivered.

 I thought I was possessed by something from hell. I thought I was going to die. Then the coughing started.

This was not the upset stomach that I’ve heard others describe as the “intestinal flu,” or the sniffles that more likely herald the onset of an annoying but relatively harmless cold. This was the real thing. I wanted never to encounter it again. So far, I haven’t.

Today, as the flu-bearing Orthomyxoviridae begin to microbe their insidious ways across the land for the seasonal onslaught, flu shot skeptics – some of them high caliber, like the Johns Hopkins scientist who spoke up last May – are making noise again, and the voice of opposing research is trying to be heard in the mainstream media. The Centers for Disease Control and prevention (CDC) bangs the same drum as always, adjusted for what’s believed to lie ahead.

As of mid-August, according to the CDC, seven flu vaccine makers were projecting that as many as 159 million doses will be available, with about 77 million of those made as quadrivalent shots, protecting against four strains. Of course, it’s a dice game annually as to whether the shots are properly made to protect against the flu varieties coming our way. But it’s a game worth the toss, I think.

So I’m getting in line again to fight the demon. Are you getting a flu shot this year? Consider this as an informal, private survey. I won’t tell anyone.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 12, 2026
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing